Danaher Q1 2024 beats expectations with $5.8B revenue, $1.92 adj EPS

DANAHER CORP /DE/

2024-Q1 EPS reported $1.45 revenue$5,796,000,000

Net earnings $1.1B, diluted EPS $1.45; adjusted diluted EPS $1.92.
Revenue $5.8B, down 2.5% YoY; core revenue down 4.0%.
Operating cash flow $1.7B; free cash flow $1.4B.
CEO reports improving bioprocessing order trends and market share gains in molecular diagnostics at Cepheid.
Q2 core revenue expected down mid-single digits; full year 2024 core revenue expected down low-single digits.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

DANAHER CORP /DE/ reported the quarter ended March 29, 2024 results: revenue $5.8 billion, net income $1.1 billion, EPS $1.45 per diluted common share.

Period: the quarter ended March 29, 2024
Revenue: $5.8 billion
Net income: $1.1 billion
EPS: $1.45 per diluted common share
Result: reported results

Exact text from the filing

earnings were $1.1 billion, or $1.45 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.92. • Revenues decreased 2.5% year-over-year to $5.8 billion and non-GAAP core revenue decreased 4.0%. • Operating cash flow was $1.7 billion and non-GAAP free cash flow was $1.4 billion. Rainer M. Blair, President and Chief Executive

View on SEC.gov

1344 earnings releases filed in the last 30 days. Browse all earnings releases →

DANAHER CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000313616-24-000106

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.